This inventor holds 1 USPTO granted patent. Top assignee: Davisco Foods International, Inc.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Line Gourley: Innovator in Antihypertensive Peptides
Introduction
Line Gourley is a notable inventor based in Québec, Canada. She has made significant contributions to the field of biotechnology, particularly in the development of antihypertensive peptides derived from whey proteins. Her innovative work has the potential to impact health and wellness, especially in the treatment of hypertension.
Latest Patents
Line Gourley holds a patent for her invention titled "Enzymatic treatment of whey proteins for the production of antihypertensive peptides and the resulting products." This patent involves the preparation of enzymatic digests of whey protein concentrates using various proteases. The research demonstrated that the highest ACE-inhibitory activity was achieved with the purified peptide β-1g (f142–148), which was synthesized chemically. The study found an IC value of 0.04 mg powder/ml for this peptide. Additionally, hydrolysates derived from BiPRO™ whey protein isolate and β-1g exhibited higher antihypertensive activities compared to other tested hydrolysates. The recovered hydrolysate has potential applications in treating hypertension in both humans and domestic pets.
Career Highlights
Line Gourley is currently employed at Davisco Foods International, Inc. Her work at this company has allowed her to explore innovative solutions in food science and health-related applications. With a focus on enzymatic treatments, she has contributed to advancements in the production of beneficial peptides.
Collaborations
Line collaborates with esteemed colleagues, including Martin E. Davis and Anand Rao. These partnerships enhance her research and development efforts, fostering a collaborative environment that drives innovation.
Conclusion
Line Gourley's work in the field of antihypertensive peptides showcases her dedication to improving health outcomes through innovative research. Her contributions to biotechnology are paving the way for new treatments for hypertension, benefiting both humans and animals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile